Comgest Global Investors S.A.S. Sells 17,075 Shares of Relx Plc $RELX

Comgest Global Investors S.A.S. reduced its holdings in shares of Relx Plc (NYSE:RELX) by 30.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,893 shares of the technology company’s stock after selling 17,075 shares during the quarter. Comgest Global Investors S.A.S.’s holdings in Relx were worth $1,905,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Orion Porfolio Solutions LLC increased its stake in Relx by 622.0% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 1,350,189 shares of the technology company’s stock valued at $73,369,000 after buying an additional 1,163,189 shares during the last quarter. ABC Arbitrage SA grew its holdings in shares of Relx by 188.9% in the 2nd quarter. ABC Arbitrage SA now owns 560,958 shares of the technology company’s stock valued at $30,482,000 after acquiring an additional 366,761 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Relx by 10.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,344,134 shares of the technology company’s stock valued at $181,569,000 after acquiring an additional 303,002 shares in the last quarter. Evelyn Partners Asset Management Ltd acquired a new stake in shares of Relx in the second quarter valued at about $11,649,000. Finally, SCS Capital Management LLC raised its holdings in Relx by 341.1% during the second quarter. SCS Capital Management LLC now owns 238,768 shares of the technology company’s stock worth $12,975,000 after acquiring an additional 184,643 shares in the last quarter. Institutional investors own 15.02% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on RELX shares. Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft upgraded shares of Relx from a “hold” rating to a “buy” rating in a report on Tuesday, December 9th. Citigroup initiated coverage on shares of Relx in a research note on Monday, January 12th. They issued a “neutral” rating for the company. Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research note on Sunday. Finally, Zacks Research raised shares of Relx from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 6th. Two equities research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Relx has a consensus rating of “Buy”.

Relx Stock Up 0.3%

NYSE:RELX opened at $30.54 on Thursday. The firm’s fifty day moving average price is $37.95 and its two-hundred day moving average price is $42.60. Relx Plc has a one year low of $27.57 and a one year high of $56.33. The company has a current ratio of 0.49, a quick ratio of 0.44 and a debt-to-equity ratio of 2.38.

Relx (NYSE:RELX) last announced its earnings results on Thursday, February 12th. The technology company reported $0.43 EPS for the quarter, missing the consensus estimate of $0.85 by ($0.42). The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $6.70 billion. On average, analysts anticipate that Relx Plc will post 1.68 EPS for the current year.

Relx Announces Dividend

The company also recently declared a dividend, which will be paid on Wednesday, June 24th. Investors of record on Friday, May 8th will be issued a dividend of $0.6559 per share. This represents a yield of 422.0%. The ex-dividend date of this dividend is Friday, May 8th.

Relx Profile

RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.

RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.